Introduction
Influenza A(H3N2) virus has continued to infect humans since its emergence as a pandemic virus in 1968, resulting in considerable economic burden, hospitalisations and deaths [1] . After half a century of circulating in humans, A(H3N2) virus has accumulated numerous amino acid substitutions in its haemagglutinin (HA) to escape from human antibodies against this protein. Mouse monoclonal antibodies identified five major antigenic sites, A through E, on HA [2, 3] and amino acid substitutions at these major antigenic sites are associated with antigenic drift. Based on the antigenicity of HA, A(H3N2) viruses form antigenic clusters [4] . Seven positions i.e. 145 at antigenic site A and 155, 156, 158, 159, 189 and 193 at antigenic site B, are mainly responsible for antigenic cluster transitions [5] . In addition, modification of HA with N-linked glycans also affects the antigenicity of HA via steric hindrance at these antigenic sites [6, 7] .
Seven A(H3N2) clades (designated clades 1 to 7) and many subclades have evolved since 2009. Between 2011 and 2012, clade 3 viruses dominated and formed subgroups, clades 3A, 3B and 3C [8] ; clade 3C viruses evolved further and subdivided into clades 3C. 1, 3C.2 and 3C.3 [9] In 2014, three new genetic subgroups emerged 3C.2A, 3C.3A and 3C.3B [10] .
During the 2014/15 influenza season, the majority of reported influenza infections in Japan were caused by A(H3N2) viruses of clade 3C.2A [11] , whereas in the 2015/16 influenza season only a few infections caused by A(H3N2) virus were reported [12] . Therefore, the 2016/17 and 2017/18 influenza vaccines contained antigens from a virus of clade 3C.2A [13] . Here, we analysed the HA sequences of A(H3N2) viruses detected in Yokohama, Japan during the 2016/17 and 2017/18 influenza seasons to capture the epidemic trend of A(H3N2) virus infection.
Methods

Study samples
Clinical specimens were collected in sentinel clinics and hospitals as part of the national epidemiological surveillance of infectious diseases in Japan during the 2016/17 and 2017/18 influenza seasons. These specimens were tested by reverse transcription (RT)-quantitative PCR (RT-qPCR) targeting H3-HA gene [14] and virus isolation was achieved by using AX4 cells.
Cells and culture
AX4 cells and (Madin-Darby canine kidney (MDCK)-β-galactoside α2,6-sialyltransferase I (SIAT1) cells, which express higher amounts of six-linked sialic acids on their cell surface via exogenous expression of human SIAT1 (or ST6Gal I) [15, 16] were maintained in Eagle's minimal essential medium (MEM) containing 10% fetal calf serum (FCS) and Dulbecco's modified eagle medium (DMEM) containing 5% fetal calf serum and 1 mg/mL G418 sulphate (ThermoFisher Scientific, Tokyo, Japan), respectively. Both cell lines were incubated at 37 °C under 5% CO 2 and were passaged by the standard procedure. 
Viruses
Sequence analysis
Viral RNA was extracted from the isolated viruses by using an RNeasy Mini Kit (QIAGEN, Tokyo, Japan). The viral RNA was subjected to one step RT-PCR to amplify the HA gene by PCR using the AccessQuick RT-PCR system (Promega, Madison, Wisconsin, United States of America (USA)) as follows: after 45 minutes of cDNA synthesis at 48 °C and 2 minutes of denaturation at 4O5N ) were added to the N-linked glycosylation sites in the crystal structure by using the GlyProt web server and were visualised by using the molecular graphics system PyMOL. Consensus sequences of clades 3B, 3C.1 and 3C.2A, and representative isolates of each clade, were used. Newly emerged N-linked glycans at N45, N144 and N158 are shown in red and the lost glycans at N122 and N133 are shown in light pink. Other N-linked glycans are shown in cyan. The receptor-binding site is shown in yellow.
94 °C, samples were subjected to 40 cycles of amplification, consisting of 1 minute at 94 °C, 90 seconds at 55 °C and 2 minutes at 68 °C, with a final additional extension step at 68 °C for 10 minutes. The PCR products were purified with a QIAquick PCR Purification Kit (QIAGEN, Tokyo, Japan) and then sequenced using a BigDye Terminator v1.1 cycle sequencing kit (Applied Biosystems, Foster City, California (CA), USA) on an ABI 3500 sequencer (Applied Biosystems, Foster City, CA, USA).
Phylogenetic analysis
The phylogenetic tree was constructed by using the neighbour-joining method with Kimura distances and the bootstrap procedure (n = 1,000) using 
Three-dimensional mapping
Amino acid positions were plotted on an HA trimer of A/Victoria/361/2011 (PDB ID code 4O5N) by using the Python-enhanced molecular (PyMOL) molecular graphics system version 1.3. The N-glycans on the HA trimer were added to the N-linked glycosylation sites by using the GlyProt web server (http://www.glycosciences.de/ modeling/glyprot/php/main.php) and visualised by using the PyMOL software.
Ferret antisera
The ferret antisera were produced at an animal production and supply company (Japan SLC, Inc. [17] ), with the approval of Japan's Institutional Animal Care and Use Committee of the National Institute of Infectious Diseases. Adult male ferrets that were serologically negative for influenza viruses were infected with the indicated A(H3N2) virus via the respiratory tract as a viral vapour generated by a nebuliser. At 2 weeks after infection, whole blood collected from the ferrets under anaesthesia was coagulated. The serum supernatants after centrifugation were collected as the antiserum. The serum samples were treated with receptor destroying enzyme (RDE) II (SEIKEN, Niigata, Japan), according to the manufacturer's instructions before use in the virus micro-neutralisation assay.
Antigenic analysis
An in vitro virus micro-neutralisation assay, based on the concept of plaque reduction, was conducted. Briefly, after 50 μl of twofold serial dilutions of the ferret antisera in DMEM containing 200 nM oseltamivir was added to a monolayer of MDCK-SIAT1 cells in a 96-well plate, 1,000 focus-forming units of the indicated virus (50 µl) was added to each well. After a 1 hour incubation, 1.6% Avicel RC-581 (FMC BioPolymer) in DMEM was overlaid. Oseltamivir was used to prevent receptor binding via NA, and trypsin was not added to avoid virus multiplication. At 18-20 hours after infection, the cells were stained with mouse antinucleoprotein (NP) monoclonal antibodies (MAB8257 and MAB8258; Millipore, Consett, US), followed by an anti-mouse IgG antibody conjugated with horseradish peroxidase. NP-positive cells were visualised with KPL TrueBlue substrate (Kirkegaard and Perry Laboratories) to count foci. The reciprocal number of the minimum dilution of sera needed to achieve 50% focus reduction was used as the neutralisation titre.
Antigenic cartography
The neutralisation data were analysed with antigenic cartography, which is a method to visualise and increase the resolution of neutralisation results, as detailed previously [4, 18] . Diagnostic plots showed that three dimensions and a column basis titre of 1,280 were suitable for representing these neutralisation data.
Ethical statement
All experiments with ferrets were performed in accordance with the institutional Regulations for Animal Care and Use and were approved by the Japan's Institutional Animal Care and Use Committee of the National Institute of Infectious Diseases.
Results
A(H3N2) viruses circulating in Yokohama, Japan
During the 2016/17 and 2017/18 influenza seasons, we detected 227 A(H3N2) viruses from clinical samples collected in Yokohama; 225 viruses were isolated using AX4 cells and two were positive by RT-qPCR ( Figure  1 ). The HA sequences were determined by Sanger sequencing and HA genetic clades were determined based on reference isolates available through EpiFlu To draw the phylogenetic tree using the neighbourjoining method with Kimura distances, we selected several isolates as representative of each clade. We found that A(H3N2) viruses isolated during the 2016/17 and 2017/18 influenza seasons in Yokohama could be classified into six clades: 3C.2A1, 3C.2A1a, 3C.2A1b, 3C.2A2, 3C.2A3, and 3C.2A4 ( Figure 1 and Figure 2A ), based on the World Health Organization (WHO) designations. We considered one case to be a co-infection with A(H3N2) viruses of two different clades because we detected HA sequences of clades 3C.2A1a and 3C.2A4. Isolates of all six clades were detected during the 2016/17 influenza season, whereas several isolates of clades 3C.2A1b, 3C.2A2, and 3C.2A3 and no isolates of clades 3C.2A1, 3C.2A1a and 3C.2A4 were detected during the 2017/18 influenza season ( Figure  1 ). These results demonstrate that several different clades of A(H3N2) viruses simultaneously caused influenza in Yokohama and the diversity of the circulating clades differed between the 2016/17 and the 2017/18 influenza seasons; the vaccine strain for A(H3N2) virus component was identical between two seasons, A/ Hong Kong/4801/2014 [13] .
Changes in the N-linked glycosylation sites on H3-HA
We next focused on the putative N-linked glycosylation sites on the H3-HA molecule because gradual accumulation of putative N-linked glycosylation sites has been linked to escape from human antibody pressure [19] . 
Antigenicity analysis
Since the phylogenetic tree revealed that A(H3N2) viruses that were distinct in terms of their HA sequence and number of HA glycosylation sites co-circulated in Yokohama during the 2016/17 and 2017/18 influenza seasons, we examined the antigenicity of viruses from different clades using sera obtained from infected ferrets. We prepared ferret antisera by infecting ferrets with each of five influenza A (H3N2) (Figure 2A ). For the antigenicity analysis, we selected 16 isolates (Table 1) . We compared the HA sequence of the selected isolates with that of A/Hong Kong/7127/2014 (Hong Kong/7127, clade 3C.2A) at antigenic sites A through E [2, 3] and mapped them onto the H3-HA molecule ( Figure 3 and Table 2 ). All six isolates possessed one or two substitutions at antigenic site D. An amino acid substitution at antigenic site A or E was found in five or four isolates, whereas that at antigenic site B or C was found in one or two isolates. positions 135-137. All of the tested viruses were isolated and passaged using MDCK cells or derivative AX4 or MDCK-SIAT1 cells.
Using the five kinds of ferret antisera and the 16 isolates, we performed an in vitro virus neutralisation assay based on the concept of plaque reduction (Table  1) . We then constructed an antigenic map to visualise these neutralisation data. This map revealed that clade 3C.2A2 (green circles) and 3C.2A4 (orange circles) viruses differed antigenically from other clades ( 
Discussion
Here, we showed that genetically and antigenically distinct A(H3N2) viruses co-circulated in Yokohama, Japan during the 2016/17 and 2017/18 influenza seasons. In London and Thailand, two subclades of A(H3N2) viruses, clades 3C.2A1 (denoted these as groups I to III in their study [20] ) and 3C.2A3 (denoted as clade 3C.2A2 or group IV in their study [21] ), were mainly responsible for the epidemics in these locations. In some cases in Thailand, A(H3N2) viruses of clade 3C.2A4 (the authors denoted these as group V) were also detected [21] . These reports, together with our results, suggest that multiple clades of A(H3N2) viruses circulated during this recent influenza epidemic. Indeed, co-circulation of multiple subclades of A(H3N2) virus, including clades 3C.2A1a, 3C.2A1b, 3C.2A2, 3C.2A3 and 3C.2A4, was also found by sequence analysis of Australian samples during the 2017 season and was documented in an early report of the 2017/18 influenza season in Canada [22, 23] . In Taiwan, clade 3C.2A3 viruses were more commonly isolated from patients with severe infections; clade 3C.2A4 viruses tended to be isolated in outbreaks [24] . Although the seven residues of HA responsible for major antigenic cluster transition [5] were not changed, the antigenicity of representative isolates of clades 3C.2A2 and 3C.2A4 differed from that of isolates of other clades. Furthermore, N-linked glycosylation sites of HA have frequently changed in recent years, which has likely affected the antigenicity of the viruses [25] . In particular, the N-glycan at positions 158-160 (NYT), which is conserved among isolates of clade 3C.2A, likely affects antigenicity because An antigenic 3D map was generated from the neutralisation data in Table 1 . Viruses are represented as circles and antisera as squares. Strains are coloured based on the clades. The grid indicates one unit of antigenic distance, a twofold dilution in neutralisation titre.
it sterically hides the residues at positions 156, 158 and 159 that are responsible for major antigenic cluster transition [5] . These reports, together with our results, show that multiple clades of A (H3N2) 
